Low Concentration Wheat Germ Extract for Viral Capsid Assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell-free systems using high concentrations of wheat germ extract for protein expression and viral capsid assembly fail to correlate effectively with antiviral drug sensitivity in vitro to their efficacy against live viruses in cell culture, lacking sensitivity and accuracy in drug screening.
Innovation Solution
A cell-free system utilizing 3 to 5% wheat germ extract for protein expression and viral capsid assembly, which provides improved correlation between drug sensitivity in vitro and antiviral efficacy against infectious viruses, allowing for more accurate drug screening and modulation of protein-protein interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If high concentration of wheat germ extract (20-50%) is used for protein expression, then protein synthesis efficiency is improved, but correlation with antiviral drug sensitivity is lost
Solution Approach 1:
The patent applies parameter changes by optimizing the wheat germ extract concentration from the conventional high range (20-50%) to a specific lower range (3-5%). This parameter adjustment resolves the contradiction by finding the optimal concentration point that simultaneously maintains adequate protein synthesis efficiency while restoring accurate correlation with antiviral drug sensitivity, enabling both productive protein expression and reliable drug screening
2Productivity
If high concentration of wheat germ extract is used for capsid assembly, then assembly efficiency is improved, but sensitivity to antiviral compounds is reduced
Solution Approach 1:
The patent applies parameter changes by establishing the optimal wheat germ extract concentration range (3-5%) for capsid assembly reactions. This parameter optimization resolves the contradiction by demonstrating that this specific concentration range maintains sufficient capsid assembly efficiency while preserving sensitivity to antiviral compounds, unlike higher concentrations that reduce compound sensitivity
3Strength
If wheat germ extract concentration is increased to maximize protein expression, then expression robustness is improved, but accuracy in drug screening is reduced
Solution Approach 1:
The patent applies parameter changes by defining the optimal wheat germ extract concentration (3-5%) that balances expression robustness with drug screening accuracy. This parameter optimization resolves the contradiction by showing that this concentration range provides sufficient protein expression robustness for reliable assays while maintaining the sensitivity and accuracy needed for accurate antiviral drug screening
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
The invention provides a cell-free system comprising not more than about 5% wheat germ extract for expressing proteins such as viral proteins and proteins required for viral capsid assembly, and proteins that assemble into multiprotein complexes in a manner analogous to viral capsids, are provided. Further provided are methods for expressing proteins such as viral proteins, proteins required for capsid assembly, and proteins that assemble into multiprotein complexes in a manner analogous to viral capsids using a cell-free system comprising not more than about 5% wheat germ extract. Further provided are methods to assay for compounds that modulate viral protein, viral capsid assembly, and assembly of proteins into multiprotein complexes whose disruption can ameliorate bacterial, parasitic, metabolic, oncologic, immunologic, or CNS disease in a cell-free system comprising not more than about 5% wheat germ extract.